These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12638641)

  • 1. The status of serotonin-selective pharmacotherapy in the treatment of alcohol dependence.
    Pettinati HM; Kranzler HR; Madaras J
    Recent Dev Alcohol; 2003; 16():247-62. PubMed ID: 12638641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of serotonin (5-hydroxytryptamine) reuptake inhibitors in the treatment of alcoholism.
    Lejoyeux M
    Alcohol Alcohol; 1996 Mar; 31 Suppl 1():69-75. PubMed ID: 8737004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of serotonin (5-HT) and opiate-based drugs in the pharmacotherapy of alcohol dependence: an overview of the preclinical data.
    Lê AD; Tomkins DM; Sellers EM
    Alcohol Alcohol; 1996 Mar; 31 Suppl 1():27-32. PubMed ID: 8736998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of selective serotonin reuptake inhibitors in treating alcoholic subtypes.
    Pettinati HM
    J Clin Psychiatry; 2001; 62 Suppl 20():26-31. PubMed ID: 11584872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin's Complex Role in Alcoholism: Implications for Treatment and Future Research.
    Marcinkiewcz CA; Lowery-Gionta EG; Kash TL
    Alcohol Clin Exp Res; 2016 Jun; 40(6):1192-201. PubMed ID: 27161942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of serotonin selective pharmacotherapy in the treatment of alcohol dependence.
    Pettinati HM
    Alcohol Clin Exp Res; 1996 Oct; 20(7 Suppl):23A-29A. PubMed ID: 8904991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin-altering medications and desire, consumption and effects of alcohol-treatment implications.
    Naranjo CA; Bremner KE
    EXS; 1994; 71():209-19. PubMed ID: 8032152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacology of serotonin-altering medications for decreasing alcohol consumption.
    Naranjo CA; Bremner KE
    Alcohol Alcohol Suppl; 1993; 2():221-9. PubMed ID: 7748304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxiety and alcoholism: a serotonin link.
    Tollefson GD
    Br J Psychiatry Suppl; 1991 Sep; (12):34-9. PubMed ID: 1840761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurobehavioural basis for the pharmacotherapy of alcoholism: current and future directions.
    Anton RF
    Alcohol Alcohol; 1996 Mar; 31 Suppl 1():43-53. PubMed ID: 8737000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the serotonergic system in the neurobiology of alcoholism: implications for treatment.
    Johnson BA
    CNS Drugs; 2004; 18(15):1105-18. PubMed ID: 15581381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of serotonin (5-hydroxytryptamine) reuptake inhibitors in the treatment of alcoholism.
    Lejoyeux M
    Alcohol Alcohol Suppl; 1996 Mar; 31(1):69-75. PubMed ID: 9845041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype.
    Pettinati HM; Volpicelli JR; Kranzler HR; Luck G; Rukstalis MR; Cnaan A
    Alcohol Clin Exp Res; 2000 Jul; 24(7):1041-9. PubMed ID: 10924008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current pharmacotherapies of alcoholism: a U.S. perspective.
    Anton RF; Swift RM
    Am J Addict; 2003; 12(s1):s53-s68. PubMed ID: 14972780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective serotonin re-uptake inhibitor treatment-emergent sexual dysfunction: randomized double-blind placebo-controlled parallel-group fixed-dose study of a potential adjuvant compound, VML-670.
    Baldwin D; Hutchison J; Donaldson K; Shaw B; Smithers A
    J Psychopharmacol; 2008 Jan; 22(1):55-63. PubMed ID: 17715211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medications acting on the serotonergic system for the treatment of alcohol dependent patients.
    Kenna GA
    Curr Pharm Des; 2010; 16(19):2126-35. PubMed ID: 20482508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reassessing the contraindication of zolmitriptan and serotonin reuptake inhibitors: an evidence-based pharmacotherapeutic case report.
    Boutilier AS; Gardner DM
    J Clin Pharm Ther; 2003 Feb; 28(1):69-72. PubMed ID: 12605621
    [No Abstract]   [Full Text] [Related]  

  • 18. New onset alcohol dependence linked to treatment with selective serotonin reuptake inhibitors.
    Atigari OV; Kelly AM; Jabeen Q; Healy D
    Int J Risk Saf Med; 2013; 25(2):105-9. PubMed ID: 23796469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poorer Drinking Outcomes with Citalopram Treatment for Alcohol Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Charney DA; Heath LM; Zikos E; Palacios-Boix J; Gill KJ
    Alcohol Clin Exp Res; 2015 Sep; 39(9):1756-65. PubMed ID: 26208048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined serotonin syndrome and hyponatraemia caused by a citalopram-buspirone interaction.
    Spigset O; Adielsson G
    Int Clin Psychopharmacol; 1997 Jan; 12(1):61-3. PubMed ID: 9179637
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.